Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP23-002, Improving Health Outcomes for Patients With Inflammatory Bowel Disease; Amended Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 6, 2023

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 24 (Monday, February 6, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 24 (Monday, February 6, 2023)]
[Notices]
[Page 7729]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-02476]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--DP23-002, Improving Health Outcomes for Patients 
With Inflammatory Bowel Disease; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--DP23-002, Improving Health Outcomes for Patients with 
Inflammatory Bowel Disease; March 8, 2023, 11:00 a.m.-3:00 p.m., EST, 
Teleconference, in the original FRN. The meeting was published in the 
Federal Register on December 9, 2022, Volume 87, Number 236, page 
75632.
    The meeting is being amended to change the meeting time and should 
read as follows:
    Date: March 8, 2023.
    Time: 10:00 a.m.-3:00 p.m., EST.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Catherine Barrett, Ph.D., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-3, Atlanta, 
Georgia 30341-3717; Telephone: (404) 718-7664; Email: <a href="/cdn-cgi/l/email-protection#abe8e9cad9d9cedfdfebc8cfc885ccc4dd"><span class="__cf_email__" data-cfemail="abe8e9cad9d9cedfdfebc8cfc885ccc4dd">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-02476 Filed 2-3-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 6, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.